Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)

Koo Foundation Sun Yat-Sen Cancer Center ( Site 0091), Taipei

Taipei Veterans General Hospital ( Site 0089), Taipei

Taipei Medical University Shuang Ho Hospital ( Site 0090), New Taipei City

National Taiwan University Hospital Hsin-Chu Branch ( Site 0087), Hsinchu

Semmelweis Egyetem ( Site 0210), Budapest

Tudogyogyintezet Torokbalint ( Site 0205), Törökbálint

Wollongong Private Hospital ( Site 0005), Wollongong

Orange Health Services ( Site 0002), Orange

Ballarat Oncology and Haematology Services ( Site 0008), Wendouree

Borsod-Abauj-Zemplen Megyei Kozponti Korhaz es Egyetemi Oktatokorhaz ( Site 0202), Miskolc

CRU Hungary KFT ( Site 0209), Miskolc

The Prince Charles Hospital ( Site 0011), Chermside

Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 0203), Szolnok

Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 0207), Gyula

St John of God Murdoch Medical Clinic ( Site 0001), Perth

Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 0217), Kaposvár

Petz Aladar Megyei Oktato Korhaz ( Site 0213), Győr

National Taiwan University Hospital ( Site 0088), Taipei

Gleneagles Penang ( Site 0066), Pulau Pinang

Hospital Pulau Pinang. ( Site 0065), George Town

AS Ida-Tallinna Keskhaigla ( Site 0161), Tallinn

SA Pohja-Eesti Regionaalhaigla ( Site 0162), Tallinn

Seoul National University Bundang Hospital ( Site 0075), Seongnam-si

Medica Sur S.A.B de C.V. ( Site 0384), Mexico City

Instituto Nacional de Cancerologia. ( Site 0382), Mexico City

Cherkasy Regional Hospital ( Site 0336), Cherkasy

Podillya Regional Center of Oncology ( Site 0343), Vinnytsia

Anne Arundel Medical Center Oncology and Hematology ( Site 0514), Annapolis

CHU Jean Minjoz ( Site 0167), Besançon

Ukranian Center of TomoTherapy ( Site 0344), Kropyvnytskiy

Hospital Tengku Ampuan Afzan ( Site 0062), Kuantan

Cone Health Cancer Center at Alamance Regional ( Site 0527), Greensboro

Chungbuk National University Hospital ( Site 0079), Cheongju-si

Northwest Georgia Oncology Centers PC ( Site 0518), Marietta

Florida Hospital ( Site 0526), Orlando

Centro di Riferimento Oncologico CRO ( Site 0235), Aviano

ICM Val D Auerelle ( Site 0177), Montpellier

Dokuz Eylul Universitesi Arastirma Uygulama Hastanesi ( Site 0314), Izmir

CHU de Grenoble - Hopital Michallon ( Site 0169), La Tronche

University of Kentucky School of Medicine & Hospitals ( Site 0517), Lexington

Necmettin Erbakan Universitesi Meram Tip Fakultesi ( Site 0321), Konya

Genesis Cancer Care Center ( Site 0559), Zanesville

Ulsan University Hospital ( Site 0077), Ulsan

Consultorios de Medicina Especializada del Sector Privado ( Site 0388), Guadalajara

Institut de Cancerologie de l Ouest Centre Rene Gauducheau ( Site 0185), Saint-Herblain

Beacon Hospital Sdn Bhd ( Site 0067), Petaling Jaya

Parkview Cancer Center ( Site 0542), Fort Wayne

Ospedale Santa Maria delle Croci ( Site 0232), Ravenna

City Clinical Hosp.4 of DCC ( Site 0338), Dnipro

Munson Medical Center ( Site 0512), Traverse City

A.O. Universitaria Careggi ( Site 0236), Florence

SA Tartu Ulikooli Kliinikum ( Site 0160), Tartu

Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 0323), Sakarya

Samsun Medical Park Hastanesi ( Site 0320), Samsun

Park Nicollet Frauenshuh Cancer Center ( Site 0554), Saint Louis Park

University Malaya Medical Centre ( Site 0061), Kuala Lumpur

Billings Clinic Cancer Center ( Site 0508), Billings

Regional Centre of Oncology-Thoracic organs ( Site 0337), Kharkiv

Illinois Cancer Care, PC ( Site 0557), Peoria

Institut Kanser Negara - National Cancer Institute ( Site 0063), Putrajaya

Centre Hospitalier de la Cote Basque ( Site 0173), Bayonne

MI Odessa Regional Oncological Centre ( Site 0333), Odesa

University of Missouri Health Care ( Site 0555), Columbia

Oaxaca Site Management Organization SC ( Site 0389), Oaxaca City

National Cheng Kung University Hospital ( Site 0086), Tainan City

Institut Curie ( Site 0166), Paris

CHU de Rouen ( Site 0174), Rouen

MI Precarpathian Clinical Oncology Center ( Site 0346), Ivano-Frankivsk

Central Texas Veterans Healthcare System ( Site 0533), Temple

Lviv State Oncology Regional Treatment and Diagnostic Center ( Site 0341), Lviv

CHU Amiens Sud ( Site 0182), Amiens

Centre hospitalier Toulon Sainte-Musse ( Site 0172), Toulon

Azienda Ospedaliera San Giuseppe Moscati ( Site 0234), Avellino

Ironwood Cancer & Research Centers ( Site 0541), Chandler

Universita Magna Grecia ( Site 0230), Catanzaro

Centro de Estudios de Investigacion Metabolicos y Cardiovasculares ( Site 0381), Madero

Scripps Cancer Center ( Site 0521), La Jolla

Institut Curie - Centre Rene Huguenin ( Site 0181), Saint-Cloud

CBCC Global Research, Inc. ( Site 0532), Bakersfield

Sarawak General Hospital ( Site 0064), Kuching

Oregon Health Sciences University ( Site 0544), Portland

Presidio Ospedaliero San Vincenzo ( Site 0231), Taormina

Alaska Clinical Research Center ( Site 0511), Anchorage

Peking Union Medical College Hospital ( Site 0105), Beijing

Beijing Cancer Hospital ( Site 0102), Beijing

Beijing Chest Hospital Capital Medical University ( Site 0111), Beijing

The First Hospital of Jilin University ( Site 0110), Changchun

SBHI Leningrad Regional Clinical Hospital ( Site 0263), Saint Petersburg

Railway Hospital of OJSC ( Site 0268), Saint Petersburg

City Clinical Oncology Center ( Site 0260), Saint Petersburg

Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 0374), Valledupar

Zhongshan Hospital Fudan University ( Site 0100), Shanghai

Jiangsu Cancer Hospital ( Site 0101), Nanjing

Shanghai Chest Hospital ( Site 0112), Shanghai

Anhui Provincial Hospital ( Site 0108), Hefei

Oncomedica S.A. ( Site 0372), Montería

The First Affiliated Hospital of Anhui Medical University ( Site 0113), Hefei

The First Affiliated Hospital Zhejiang University ( Site 0106), Hangzhou

Hangzhou First People's Hospital ( Site 0109), Hangzhou

2nd Affil Hosp of Zhejiang University College of Medicine ( Site 0114), Hangzhou

Zhejiang Cancer Hospital ( Site 0116), Hangzhou

Xiangya Hospital of Central South University ( Site 0115), Changsha

Hunan Cancer Hospital ( Site 0104), Changsha

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0269), Kazan'

SBHI Samara Regional Clinical Oncology Dispensary ( Site 0265), Samara

Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 0262), Ufa

West China Hospital of Sichuan University ( Site 0117), Chengdu

Krasnoyarsk Regional Clinical Oncological Dispensary ( Site 0266), Krasnoyarsk

1st Affil Hosp of Med College of Xi'an Jiaotong University ( Site 0103), XiAn

Centro Medico Imbanaco de Cali S.A ( Site 0369), Santiago de Cali

Rambam Medical Center ( Site 0223), Haifa

Bnei Zion Medical Center ( Site 0227), Haifa

Meir Medical Center ( Site 0221), Kfar Saba

Rabin Medical Center ( Site 0224), Petah Tikva

Sheba Medical Center ( Site 0220), Ramat Gan

Sourasky Medical Center ( Site 0225), Tel Aviv

Barzilai Medical Center ( Site 0226), Ashkelon

Soroka Medical Center ( Site 0222), Beersheba

Cross Cancer Institute ( Site 0400), Edmonton

Lions Gate Hospital ( Site 0407), North Vancouver

William Osler Health System (Brampton Civic Hospital) ( Site 0402), Brampton

Windsor Regional Cancer Program ( Site 0404), Windsor

McGill University Health Centre ( Site 0418), Montreal

Hospital General de Medellin Luz Castro de Gutierrez ( Site 0368), Medellín

Fundacion Centro de Investigacion Clinica CIC ( Site 0366), Medellín

Biomelab S A S ( Site 0365), Barranquilla

Azienda Ospedaliera S. Giovanni Addolorata-Oncologia Medica ( Site 0233), Rome

Policlinico Gemelli di Roma ( Site 0237), Roma

Aichi Cancer Center Hospital ( Site 0018), Nagoya

Kurume University Hospital ( Site 0025), Kurume

Hyogo Cancer Center ( Site 0021), Akashi

Kanagawa Cardiovascular and Respiratory Center ( Site 0026), Yokohama

Kanagawa Cancer Center ( Site 0023), Yokohama

Miyagi Cancer Center ( Site 0028), Natori-shi

Sendai Kousei Hospital ( Site 0022), Sendai

National Hospital Organization Kinki-chuo Chest Medical Center ( Site 0027), Sakai

Kindai University Hospital ( Site 0017), Sayama

National Hospital Organization Kyushu Medical Center ( Site 0015), Fukuoka

Kyushu University Hospital ( Site 0030), Fukuoka

Okayama University Hospital ( Site 0020), Okayama

Osaka International Cancer Institute ( Site 0019), Osaka

Toranomon Hospital ( Site 0016), Tokyo

Juntendo University Hospital ( Site 0029), Tokyo

Nippon Medical School Hospital ( Site 0024), Tokyo

Ars Medical Sp. z o.o. ( Site 0254), Piła

Krakowski Szpital Specjalistyczny im Jana Pawla II ( Site 0253), Krakow

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 0243), Krakow

Szpital Uniwersytecki im. Karola Marcinkowskiego ( Site 0247), Zielona Góra

Centrum Medyczne Pratia Ostroleka ( Site 0242), Ostrołęka

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 0252), Warsaw

Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 0250), Przemyśl

SPZOZ USK nr 1 im. Norberta Barlickiego UM w Lodzi ( Site 0256), Lodz

Asan Medical Center ( Site 0076), Seoul

SMG-SNU Boramae Medical Center ( Site 0078), Seoul

Gulhane Egitim ve Arastirma Hastanesi ( Site 0316), Ankara

Abdurrahman Yurtaslan Onkoloji Hastanesi ( Site 0318), Ankara

Baskent Universitesi Ankara Hastanesi ( Site 0319), Ankara

Antalya Memorial Hospital Department of Medical Oncology ( Site 0324), Antalya

Akdeniz Universitesi Tip Fakultesi ( Site 0322), Antalya

Medical Center Verum ( Site 0334), Kyiv

Kyiv City Clinical Oncology Centre ( Site 0339), Kyiv

Medical and Diagnostic Centre LLC Dobryi Prognoz ( Site 0331), Kyiv